PRIMECAP Odyssey Aggressive Growth (M:POAGX)

Add to Watchlists
Create an Alert
43.62 -1.38  -3.07% Dec 7 USD
View Full Chart
M:POAGX Total Returns Chart

M:POAGX Key Stats

M:POAGX Performance

  Total Return Cat. Total Return (NAV) % Rank in Cat. (NAV)
1M -7.03% -7.01% 54
3M -15.35% -13.00% 81
6M -13.45% -9.62% 88
YTD -1.60% -1.87% 50
1Y 0.19% -0.59% 45
3Y 13.85% 8.40% 5
5Y 12.80% 7.35% 2
10Y 21.07% 14.45% 1
15Y -- 8.46% --
20Y -- 8.30% --
As of Dec. 7, 2018. Returns for periods of 1 year and above are annualized.

M:POAGX Asset Allocation

Type % Net % Long % Short
Cash 4.69% 4.69% 0.00%
Stock 94.86% 94.86% 0.00%
Bond 0.00% 0.00% 0.00%
Convertible 0.00% 0.00% 0.00%
Preferred 0.45% 0.45% 0.00%
Other 0.00% 0.00% 0.00%
As of Sept. 30, 2018

M:POAGX Region Exposure

Americas 92.00%
North America 92.00%
Latin America 0.00%
Greater Europe 1.31%
United Kingdom 0.09%
Europe Developed 0.74%
Europe Emerging 0.00%
Africa/Middle East 0.47%
Greater Asia 6.69%
Japan 3.97%
Australasia 0.00%
Asia Developed 0.17%
Asia Emerging 2.55%
Market Classification
% Developed Markets 97.44%
% Emerging Markets 2.56%
As of Sept. 30, 2018. Region breakdown data is calculated by using the long position holdings of the portfolio.

M:POAGX Stock Sector Exposure

Basic Materials 0.14%
Communication Services 1.37%
Consumer Cyclical 10.21%
Consumer Defensive 2.13%
Energy 0.75%
Financial Services 3.83%
Healthcare 34.68%
Industrials 14.89%
Real Estate 0.00%
Technology 32.01%
Utilities 0.00%
As of Sept. 30, 2018

M:POAGX Stock Market Capitalization

Giant 13.40%
Large 27.31%
Medium 37.72%
Small 18.96%
Micro 2.61%
As of Sept. 30, 2018

M:POAGX Stock Style Exposure

Large Cap Value 7.66%
Large Cap Blend 19.73%
Large Cap Growth 13.73%
Mid Cap Value 6.95%
Mid Cap Blend 5.94%
Mid Cap Growth 25.07%
Small Cap Value 1.76%
Small Cap Blend 5.30%
Small Cap Growth 13.87%
As of Sept. 30, 2018
View More Holdings

M:POAGX Top 10 Holdings

Symbol Name % Weight Price % Chg
NKTR Nektar Therapeutics Inc 5.89% 36.15 -2.27%
ABMD Abiomed Inc 4.82% 321.51 +1.26%
SNE Sony Corp ADR 3.77% 50.98 -0.29%
AAL American Airlines Group Inc 2.85% 33.94 +1.10%
SGEN Seattle Genetics Inc 2.73% 60.20 +0.35%
UAL United Continental Holdings Inc 2.71% 88.67 +0.50%
MU Micron Technology Inc 2.54% 35.07 -0.68%
BB BlackBerry Ltd 2.25% 7.95 -0.62%
ALKS Alkermes PLC 2.22% 34.30 +0.85%
SPLK Splunk Inc 2.17% 107.94 +2.16%
As of Sept. 30, 2018
Advertisement

M:POAGX One Page Reports

M:POAGX Basic Info

Style
Equity Style Mid Cap/Growth
Broad Asset Class US Equity
Broad Category Equity
Category Name Mid-Cap Growth
Prospectus Objective Aggressive Growth
Fund Owner Firm Name PRIMECAP Odyssey Funds
Benchmark Index
S&P 500 TR USD
100.0%

M:POAGX Manager Info

Name Tenure
Alfred Mordecai 14.01 yrs
James Marchetti 4.00 yrs
Joel Fried 14.01 yrs
M. Ansari 6.56 yrs
Theo Kolokotrones 14.01 yrs

M:POAGX Net Fund Flows

1M -15.98M
3M 17.79M
6M 366.38M
YTD 625.30M
1Y 607.30M
3Y 358.52M
5Y 1.132B
10Y 3.947B
As of Nov. 30, 2018

M:POAGX Risk Info

Beta (5Y) 1.265
Historical Sharpe (10Y) 1.280
Historical Sortino (All) 0.9859
Daily Value at Risk (VaR) 1% (All) 3.65%
Monthly Value at Risk (VaR) 1% (All) 17.31%

M:POAGX Fundamentals

Dividend Yield TTM (12-7-18) 0.00%
30-Day SEC Yield --
7-Day SEC Yield --
Weighted Average PE Ratio 15.91
Weighted Average Price to Sales Ratio 2.024
Weighted Average Price to Book Ratio 3.555
Weighted Median ROE 13.01%
Weighted Median ROA 5.99%
Forecasted Dividend Yield 0.41%
Forecasted PE Ratio 18.28
Forecasted Price to Sales Ratio 2.050
Forecasted Price to Book Ratio 3.518
Number of Holdings 166
As of Sept. 30, 2018

M:POAGX Growth Estimates

Forecasted 5 Yr Earnings Growth 13.48%
Forecasted Book Value Growth 4.64%
Forecasted Cash Flow Growth 4.41%
Forecasted Earnings Growth 10.58%
Forecasted Revenue Growth 3.43%
As of Sept. 30, 2018

M:POAGX Comparables

Edit

M:POAGX Attributes

Purchase Details
Open to New Investors No
Open to Existing Investors Yes
Minimum Initial Investment 2000.00 USD
Minimum Subsequent Investment 100.00 USD
Fees
Actual 12B-1 Fee --
Actual Management Fee 0.55%
Administration Fee --
Performance Fee --
Switching Fee --
Transaction Fee --
Maximum Front Load --
Maximum Deferred Load --
Maximum Redemption Fee --
Key Dates
Inception Date 11/1/2004
Termination Date
Last Annual Report Date 10/31/2017
Last Prospectus Date 2/28/2018
Attributes
Exchange Traded Share No
Exchange Traded Note No
Enhanced Index Fund No
Fixed Distribution Fund No
High-Net Worth Individual Fund No
Index Fund No
Inverse Fund No
Leveraged Fund No
Fund of Funds No
Currency Hedged Fund No
Synthetic Replication Fund No
Has Dividend Investment Plan No
Socially Responsible Fund No
General Availability
Available for Insurance Product No
Available for Retirement Plan No
Available for RRSP No

M:POAGX Excel Add-In Codes

  • Name: =YCI("M:POAGX","name")
  • Broad Asset Class: =YCI("M:POAGX", "broad_asset_class")
  • Broad Category: =YCI("M:POAGX", "broad_category_group")
  • Prospectus Objective: =YCI("M:POAGX", "prospectus_objective")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.